These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Metaanalysis of statins and survival in de novo cardiac transplantation. Mehra MR; Raval NY Transplant Proc; 2004 Jun; 36(5):1539-41. PubMed ID: 15251380 [TBL] [Abstract][Full Text] [Related]
7. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study. Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242 [TBL] [Abstract][Full Text] [Related]
8. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929 [TBL] [Abstract][Full Text] [Related]
9. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients. Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928 [TBL] [Abstract][Full Text] [Related]
10. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation. Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480 [TBL] [Abstract][Full Text] [Related]
12. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression. McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506 [TBL] [Abstract][Full Text] [Related]
13. Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Wenke K; Meiser B; Thiery J; Nagel D; von Scheidt W; Steinbeck G; Seidel D; Reichart B Circulation; 1997 Sep; 96(5):1398-402. PubMed ID: 9315523 [TBL] [Abstract][Full Text] [Related]
14. A comparative analysis of outcome after heart transplantation in patients aged 60 years and older: the University of Alberta experience. Nagendran J; Wildhirt SM; Modry D; Mullen J; Koshal A; Wang SH J Card Surg; 2004; 19(6):559-62. PubMed ID: 15548193 [TBL] [Abstract][Full Text] [Related]
15. Gender differences in the outcome of cardiac interventions. Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240 [TBL] [Abstract][Full Text] [Related]
16. Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation. Jaeger BR; Meiser B; Nagel D; Uberfuhr P; Thiery J; Brandl U; Brückner W; von Scheidt W; Kreuzer E; Steinbeck G; Reichart B; Seidel D Circulation; 1997 Nov; 96(9 Suppl):II-154-8. PubMed ID: 9386091 [TBL] [Abstract][Full Text] [Related]
17. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database. Weiss ES; Nwakanma LU; Patel ND; Yuh DD J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225 [TBL] [Abstract][Full Text] [Related]
18. Safety of statins when response is carefully monitored: a study of 336 heart recipients. Marzoa-Rivas R; Crespo-Leiro MG; Paniagua-Marin MJ; Llinares-García D; Muñiz-Garcia J; Aldama-López G; Piñón-Esteban P; Campo-Pérez R; Castro-Beiras A Transplant Proc; 2005 Nov; 37(9):4071-3. PubMed ID: 16386629 [TBL] [Abstract][Full Text] [Related]